Incidence of acute haemolytic transfusion reaction among ABO‐incompatible recipients transfused with A3 blood: A case series

Author:

Latour Catherine1,Gaussen Amaury2,Beaudoin Julie3,Leiva‐Torres Gabriel André1ORCID,Rochette Samuel4ORCID,Robitaille Nancy1

Affiliation:

1. Transfusion Medicine Héma‐Québec Montréal Quebec Canada

2. Medical Affairs and Innovation Héma‐Québec Québec City Quebec Canada

3. Quality Control and Development Héma‐Québec Montréal Quebec Canada

4. Medical Affairs and Innovation Héma‐Québec Montréal Quebec Canada

Abstract

AbstractBackground and ObjectivesABO antigens are among the most immunogenic, but the haemolytic risks of ABO incompatibilities involving a donor with a weak ABO phenotype are little documented.Materials and MethodsThis retrospective case series assessed the incidence of acute haemolytic transfusion reaction (AHTR) among ABO‐incompatible recipients of A3 blood in Québec (Canada). Transfusion safety officers reported laboratory AHTR indicators measured ≤24 h pre‐ and post‐transfusion. Because the AHTR case definition of Québec's Hemovigilance System (QHS) leaves significant room for clinical judgement, a two‐step approach was used to assess potential cases: Step 1 consisted in a highly sensitive—but unspecific—initial screen that identified all candidate cases per QHS case definition, and Step 2 consisted in a detailed review of candidate cases by two haematologists.ResultsNine donors initially typed as Group B (N = 1) or O (N = 8) were subsequently found to display an A3B or A3O phenotype. Eighty‐one recipients received ABO‐incompatible blood, including 53 (65.4%) with interpretable data. Of these, 29 (54.7%) were classified as candidate cases after Step 1. Following Step 2, no conclusive evidence of AHTR was found: Abnormal pre‐ versus post‐transfusion changes appeared modest, within normal range, insufficient to ascertain AHTR, or were consistent with a pre‐existing condition unrelated to AHTR. Two candidate cases had a QHS‐reported transfusion reaction; both were unrelated to AHTR.ConclusionIn this case series, no conclusive evidence of serious AHTR was found among ABO‐incompatible recipients who were inadvertently transfused with A3 blood.

Publisher

Wiley

Subject

Hematology,General Medicine

Reference19 articles.

1. Hemolytic Transfusion Reactions

2. Transfusion reactions: prevention, diagnosis, and treatment

3. Bleeding, Hemostasis, and Transfusion Medicine

4. Comité de Biovigilance du Québec.Rapport 2016‐2017. [cited 2022 Jan 11]. Available from:https://publications.msss.gouv.qc.ca/msss/fichiers/2020/20-933-03W.pdf

5. Importance of Weak ABO Subgroups

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3